肿瘤靶向药物不良反应的药学服务关注点
Focus on pharmaceutical services for adverse reactions of tumor-targeted drugs
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |